Back to home page

AN OUTSTANDING INNOVATION POLICY

The Mérieux Research Grants

These research grants are designed to promote and identify innovative projects. They provide investigators (junior, senior, in the medical or scientific community) in public and private laboratories with the funding needed to conduct projects on infectious diseases, cancer and cardiovascular diseases, nutrition, food and water safety.

All applications go through a rigorous review process. Those that are selected are awarded a two-year grant (up to € 200,000), with Institut Mérieux having the option of establishing strategic partnerships in the event of success.

There are two types of grants:

  • Advanced Research Grants for the most innovative projects having significant strategic advantages,
  • Starting Research Grants for projects that, although interesting, must clearly demonstrate their feasibility

To know more about the Mérieux Research Grants, please click here.

Merieux Alliance

Selected projects


Mérieux Research Grants 2014

Sergio ABRIGNANIInstitute Nationale de Genetica Moleculaire – Milan - Italy

  • Serum microRNA released by CD4 T cell subsets

Anca DORHOIMax Planck Institute for Infection Biology - Berlin - Germany

  • Deciphering the cross-talk between myeloid cells and pneumocytes during lung microbial infections

Brett FINLAYUniversity of british Columbia – Vancouver - Canada

  • Use of microbiota and their metabolites to develop novel methods to control enteric infectious diseases

Michael GILMOREHarvard medical School – Boston - USA

  • Exploring the staphyllococcus aureus innate "Resistome" using next generation sequencing technology, Tn-seq

Jens HASSERODTEcole Normale Supérieure de Lyon - France

  • Pushing FACS-based detection sensitivity to new heights in the ultrahigh-throughput screening of enzyme variants

Kim LEWISNortheastern University – Boston - USA

  • Die Hard : how M Tuberculosis survives antibiotic treatment

Stephen LORYHarvard Medical School – Boston – USA

  • A comprehensive analysis of Acinetobacter baumannii virulence and host-recognition factors

Scott MANALISMIT– Cambridge - USA

  • Resonant microchannels with droplets for rapid antibiotic susceptibility testing

Sarkis K. MAZMANIANCalifornia Institute of Technology – Pasadena - USA

  • Novel Microbiome Therapies for Parkinson’s Disease

Sven PETTERSSONKarolinska Institute – Stockholm - Sweden

  • The MICROBIOM – a key player involved in the developmental programming of the brain

Kyu RHEEWeill Cornell Medical College - New York - USA

  • Metabolomic biomarkers of Mtb drug susceptibility

Henriqueta SILVAFaculté de medicine – Coimbra - Portugal

  • The pharmacogenomics in the personalization of isoniazid treatment of patients with tuberculosis

Michael SNYDERStanford University – Stanford - USA

  • Integrative omics profiling for monitoring health an disease

Simon TAYLOR ROBINSONImperial College – London - UK

  • A novel low cost, urinary diagnostic

Marc VIDALDana Farber – Boston - USA

  • Identification of Cancer Associated Rewiring Edgotypes

Marie Lucia FERRAZ (Network)University of Sao Paolo – Brazil

  • Clonal evaluation of KPC isolates from hospital complex in clinical hospitals

Fang LI (Fellowship)University of Heifei - China

  • Luminescence functionalized nanomaterials for label-free bioassays Fellowship (3K€) - 2014

Mérieux Research Grants 2013

Rory BOWDEN & Daniel WILSON & Derrick CROOKUniversity of Oxford – Oxford - UK

  • The genetic basis of virulence in Staphylococcus aureus: a whole-genome case-control study

Denis HUDRISIERIPBS – Toulouse

  • TRAP assay for a better immune monitoring of anti-TB vaccines

Ahmad KHALIL & James COLLINSBoston University and HHMI – Boston – US

  • Diagnostic Chip for Rapid Antibiotic Susceptibility Testing Using Reactive Oxygen Species in the Clinical Setting

Carsten KEMSKENSTEFFENCharité – Berlin - Gemany

  • Value of microRNA profiling to predict significant prostate cancer in a cohort qualifying for active-surveillance

Olivier LANTZInstitut Curie - Paris

  • Modulating MAIT cell activity for therapeutic purpose

Jiankang LIU / Jiangang LONGXi’An Jiaotong University - China

  • Nutritional approach to ameliorate skeletal muscle atrophy – targeting mitochondria

MA XiaojunPeking Union Medical College – Beijing - China

  • CLABSI Prevention Project in PUMCH

Ivan MATICInserm Paris

  • Induction of stress response and mutagenesis by the subinhibitory concentrations of antibiotics

MENG SongdongInstitut de Microbiology – Beijing - China

  • Heat shock protein gp96 as the T-cell adjuvant against hepatitis B virus and influenza virus

Hai QITsinghua University – Beijing - China

  • Follicular helper T cell development and function in vivo

Martine RAYMONDRockefeller University – Quebec - Canada

  • Modulation of histone H3 lysine 56 acetylation as a novel anti-fungal therapy

Ilan ROSENSHINEHebrew University – Jerusalem - Israel

  • Combating enterohemorrhagic E. coli infection by targeting its tissue-recognition mechanism

Cynthia SEARSJohns Hopkin – Batimore - US

  • Induction ot Human Colon Cancer by Bacteroides Fragilis Toxin (BFT)-producing Bacteroides Species

Charles SERHANHarvard Boston - US

  • Infection-Inflammation and Activation of Novel Resolution Mediator Programs

Yuanda SONGJiangnan University – Wuxi - China

  • Construction of a ?-3 fatty acid EPA producing cell factory by manipulating the activity and expression of ?-3 desaturase in the fungus Mortierella alpina

Rotem SOREKWeizmann Institute of Science, Rehovot, Israel

  • Pàan-genomic discovery of novel antibiotics biosynthesis pathways

Luc TEYTONScripps – La Jolla - US

  • Development pf a new fof immunomodulators using High Troughput screening

Pierre TISSIERESInserm – Faculté de médecine – Paris – France

  • Regulatory mechanisms of innate immune genes splicing

Michael VOSEGERHospital of the University of Munich - Germany

  • Drug monitoring of antibiotics in critical care patients

Hong-Rui WANG Xiamen University – Fujian - China

  • Relationship between levels of N-acetyl amino acids and tumorigenesis

Ada YONATHInstitut Weizmann, Rehovot - Israel

  • Towards minimizing resistance to antimicrobials

YU ChundongXiamen University – Xiamen – China

  • The role of steroid receptor coactivator 3 (SRC-3) in host defense against bacterial infection and Role of steroid receptor coactivator 3 in bacterial colitis

Ana Tereza de VASCONCELOS (Network)Brazil

  • identification and characterization of bacterial pathogens in nosocomial infection management

Dr Chengbo RONG (Fellowship)CAS Beijing (Pr Gao) - China

  • Structural analysis of Gram-positive, bacteria type IV secretion system (T4SS)

Mérieux Research Grants 2012

Rafi AHMEDEmory University – Atlanta

  • Harnessing the mTOR pathway to enhance vaccine induced immunity

Remy BURCELINInserm – Toulouse - France

  • The identification of predictive and diagnostic blood biomarkers for type 2 diabetes and its cardiovascular complications

Jean Laurent CASANOVAThe Rockefeller University New York - US

  • Revisiting human ISG15 as a potent INF-gamma -inducing and anti-microbial cytokine.

Graham COOKS & Ouyang ZHENGPerdue university – West Lafayette US

  • Paper spray mass spectrometry: A new platform technology for rapid trace chemical analysis.

Francoise DROMERInstitut Pasteur – Paris – France

  • Biocrypto : development of biomarkers of prognosis during cryptococcosis

Carl HAUSERHarvard Medical School – Boston

  • Defining the contribution of mitochondrial peptides to SIRS after tissue injury

Birgitta HENRIQUES-NORMARKKarolinska Institut – Stockholm – Sweden

  • Early host and pneumococcal responses determining invasive disease outcome

Gerard KARSENTYColumbia University – New York - US

  • Serotonin in the whole body energy metabolism

Theo LASSEREPFL – Lausanne – Switzerland

  • SOPHIA Superresolution and Optical Phase Imaging for the Assessment of bacteria–antibiotic interactions

Oded LEWINSONTechnion – Haifa Israel

  • Mechanistic and pharmacological studies of ABC transporters that are essential to bacterial virulence

Cuihua LIUCAS Key Laboratory of Pathogenic Microbiology - beijing

  • Molecular epidemiology and molecular mechanisms of drug resistance in Klebsiella pneumoniae isolates from patients acquired nosocomial infections"

Jean François MASSONUniversity Montreal – Quebec - Canada

  • hand held sensor for monitoring chemotherapy treatments

Paolo SASSONE-CORSIUniversity of California - Irvine - US

  • Nutrition and metabolism: the epigenetic circadian link

Peter STERKUniversity Amsterdam – The Netherlands

  • Microbial fingerprinting by nano-sensor analysis of exhaled air in infants and adults with respiratory diseases

Assaf VARDI & Asaph AHARONIInstitut Weismann – Rehovot - Israel

  • Ocean metabolomics – Towards drug discovery from marine microbiota systems

HAN Lizhong (Network)Ruijin Hospital Shanghai - China

  • A molecular epidemiologic analysis of Staphylococcus aureus causing nosocomial infections among burn units

ZHANG Xinxin / SUN Hui-Chuan (Network)Rui Jin Hospital Zhongshan Hospital

  • Functional Study on N-Glycosylation Mutation in Hepatitis B Surface Antigen

REN Zefang / SU Yi (Fellowship)Sun Yat-sen University - Guangzhou,


WANG Yanyi / SHU Hong-Bin (Fellowship)Wuhan University - Hubei


ZHANG Huaiyuan / SONG Yuanda (Fellowship)Jiangnan University - Wuxi